D-dimer Testing Market to Reach $2.2 Billion Globally by 2032 at 5.1% CAGR: Allied Market Research

The growing prevalence of thrombotic disorders and the rising focus on personalized medicine & precision healthcare are projected to drive the global D-dimer testing market's growth during the forecast period. The North America region is predicted to witness prominent growth by 2032.

PORTLAND, Ore., May 23, 2024 /PRNewswire/ -- Allied Market Research has recently published a report, titled, "D-dimer Testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Test Type, by Application, by End-use : Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global D-dimer testing market generated $1.3 billion in 2022, and is anticipated to generate $2.2 billion by 2032, rising at a CAGR of 5.1% from 2023 to 2032.

Request Sample of the Report on D-dimer Testing Market Forecast 2032 -
https://www.alliedmarketresearch.com/request-sample/A298270 

Prime Determinants of Growth

The increasing prevalence of thrombotic disorders, rising demand for point-of-care D-dimer testing, and the emergence of aptamers as an alternative to antibodies are the factors expected to drive the growth of the global D-dimer testing market in the forecast period from 2023 to 2032. However, stringent regulatory requirements for D-dimer testing assays & devices and the lack of standardization may restrict market growth in the coming future. Contrarily, technological advancements and the emerging applications of d-dimer testing in new healthcare settings are expected to offer remunerative opportunities for the D-dimer testing market expansion during the forecast period.

Report Coverage & Details:

Have a Question? Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/A298270 

Test Type: Laboratory Tests Sub-segment to Thrive Significantly by 2032

The laboratory tests sub-segment accounted for the largest global D-dimer testing market share of 65.0% in 2022 and is expected to hold major share during the forecast period. Laboratory-based D-dimer tests offer efficacy and reliability in detecting fibrin degradation products, aiding in timely detection and management of thrombotic events. Their widespread adoption within clinical settings emphasizes their indispensable role in modern healthcare practices.

Application: Deep Vein Thrombosis (DVT) Sub-segment to Flourish Immensely During the Forecast Period

The deep vein thrombosis (DVT) sub-segment held the largest market share of 37.6% in 2022 and is predicted to hold major share by 2032. The prominence of D-dimer testing in diagnosing and managing deep vein thrombosis (DVT) highlights its critical role in assessing thrombotic events by detecting elevated D-dimer levels. Beyond diagnosis, it guides treatment decisions and monitors therapeutic efficacy, crucial in anticoagulant therapy. Rising awareness of thromboembolic disorders and the need for timely intervention further drive demand within the DVT sub-segment.

End-use: Hospitals Sub-segment to be the Most Dominant During the Forecast Period

The hospitals sub-segment held the largest market share of 39.2% in 2022 and is predicted to grow at the highest CAGR of 5.6% during the forecast period. As primary hubs for patient care and critical decision-making, hospitals possess the infrastructure, expertise, and resources for accurate diagnostic testing, ensuring swift assessment of patients' coagulation status and informed clinical judgments. Their prevalence and ongoing innovation in diagnostic methodologies further enhance patient care and outcomes.

For Purchase Enquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A298270 

Region: North America Market to Hold Major Share by 2032

The North America D-dimer testing market accounted for the largest share of 38.9% in 2022 and is predicted to continue to hold major share by 2032. D-dimer testing's widespread adoption across North American medical facilities, integral for evaluating thrombotic conditions and ruling out serious clotting disorders, highlights the region's commitment to proactive healthcare management. This dominance reflects the region's prioritization of early detection and intervention in thrombotic events, showcasing its role as a leader in innovative medical technologies and diagnostic methodologies.

Leading Players in the D-dimer Testing Market:

• Sekisui Diagnostics
• Thermo Fisher Scientific Inc.
• Siemen Healthineers
• Quidel Corporation
• F. Hoffmann-La Roche Ltd.
• Horiba Ltd.
• Diazyme Laboratories, Inc.
• biomerieux SA
• WERFEN
• Abbott

The report provides a detailed analysis of the key players of the global D-dimer testing market. These players are employing various strategies including launching new products, entering collaborations, expanding operations, forming joint ventures, and signing agreements, all aimed at boosting their market share and securing their competitive position across different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg